FDA OKs HeartWare device for transplant patients

The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.

Regulators approved HeartWare's Ventricular Assist System, a battery-powered device that is implanted in the chest, where it helps the heart's lower left chamber pump blood throughout the body.

The FDA has previously approved similar devices, known as ventricular assist devices, but HeartWare's device is smaller and may be easier to implant in some patients.

FDA says the approval was based on a company study of 137 advanced implanted with the device. Study results showed rates of adverse events, including infection and stroke, were similar to those seen with older devices.

Medical device maker HeartWare International Inc. is based in Framingham, Mass.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US approves first heart pump for children

Dec 18, 2011

The US Food and Drug Administration has approved a first mechanical cardiac assist device for children that can help keep patients alive as they await a transplant.

Artificial heart implants approved in U.S.

Sep 06, 2006

The use of fully implanted artificial hearts for patients with advanced heart failure was approved for use Wednesday by the U.S. Food and Drug Administration.

Recommended for you

Use of drug-eluting stents may cut in-hospital mortality

Nov 20, 2014

(HealthDay)—Use of drug-eluting stents (DES) rather than bare-metal stents (BMS) for percutaneous coronary intervention (PCI) is associated with lower rates of in-hospital mortality, according to research ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.